@article{JTD8720,
author = {Antoine Kimmoun and Chaoije Wei and Bruno Levy and Djillali Annane},
title = {Heart rate reduction may be a major determinant of vascular tone in esmolol-treated septic shock patients—although still remains to be confirmed!},
journal = {Journal of Thoracic Disease},
volume = {8},
number = {8},
year = {2016},
keywords = {},
abstract = {Over the last decade, the regulation of the autonomic nervous system by β1-adrenoreceptor antagonists in septic shock patients has been the subject of growing literature. In 2013, Morelli et al. published a randomized, controlled, open-label, single-center phase 2 trial investigating the efficacy of intravenous esmolol, a short acting β1-blocker titrated to lower heart rate (HR) in septic shock patients with severe tachycardia. This study found that esmolol was associated with a reduction in HR to the specified target range (80–94 bpm), maintained cardiac output, increased systemic vascular resistances along with a subsequent reduction in norepinephrine dose requirements (1).},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/8720}
}